HCAT NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Health Catalyst Inc · Healthcare · Health Information Services

Open interactive chart View report data
Latest close 2.09 USD
0.5% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 20.4% above the Trend Line and sits at 38.8% of its 52-week range. The latest completed week returned 0.5%, after a 0.5% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 48/100. Near-term considerations: volume confirmation is below normal; earnings are due in 5d.

Setup score 30 out of 100
Latest Close 2.09 USD 31 Jul 2026
1W Return 0.5% latest completed week
4W Return 0.5% short-term follow-through
12W Return 37.5% quarterly tape
Trend Breadth 0.0% 0 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 42.15% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.5% Latest completed week; four-week move 0.5%. Indicator stack 0/71 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 42.15% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 52/100 conviction; expected move 32.7%. News sentiment 48/100 56 relevant articles in the latest sentiment read. Event risk 5d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 20.4% above the Trend Line and sits at 38.8% of its 52-week range. The latest completed week returned 0.5%, after a 0.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4112-week average 0.23

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.41Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.5% over four weeks, 37.5% over 12 weeks, and -40.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.5%
4W0.5%
12W37.5%
26W-2.8%
52W-40.6%
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.17Latest activity-pressure read.
Pressure change-5.1%Four-week change in activity pressure.
Leadership-14.11Latest relative-leadership reading.
RS change39.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength38/100Blend of value, momentum, and quality. Underlying universe rank 63; rank 1 is best.
Value80/100Relative valuation strength. Underlying universe rank 21; rank 1 is best.
Quality10/100Profitability and accounting quality. Underlying universe rank 91; rank 1 is best.
Momentum6/100Medium-term price momentum. Underlying universe rank 95; rank 1 is best.
Growth22/100Revenue and earnings growth. Underlying universe rank 79; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
11.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
46.0%
Gross profit retained from each unit of revenue.
Operating margin
-80.2%
Operating profit retained from revenue.
Free-cash-flow margin
9.7%
Free cash flow generated from revenue.
Return on invested capital
-73.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-2.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
55.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

HCAT shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 32.7%, and Sharemaestro trend signal inactive.

Conviction52/100
Expected move32.7%
Put/call volume0.00
Pressure100
Speculation0
Volatility96
Trend agreement0
Open options detail
Insider activity7 / 6

7 acquisitions and 6 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment48/100

Weighted news tone is neutral across 56 relevant articles.

4 positive · 43 neutral · 9 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings5dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move32.7%Nearest-chain priced movement where available.
52-week drawdown-46.1%Distance below the 52-week high.
13-week volatility13.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2612 weeks finished lower.
Best week+39.9%Week of 5 Jun.
Worst week-32.3%Week of 13 Mar.
Latest week+0.5%Week of 31 Jul.

Shape of recent returns

Strong gains12
Modest gains1
Flat weeks1
Modest losses2
Sharp losses10
Recent vol13.6%13-week weekly-return volatility.
Base vol12.9%52-week weekly-return volatility.
Up/down split23/28Count of positive and negative weeks in the 52-week window.
Average skew10.7% / -9.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape23/100

Trend, activity pressure, participation, and risk combine to a 23/100 tape read.

 Indicator analysis35/100

Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 0/12.

Activity pressure 0.41; No reversal markers Next-Week ExpectancyNegative 42.15%

Next-week expectancy is negative with a 42.15% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors32/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 61; Buyback Yield rank 57; Small Cap Core rank 28 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options35/100

HCAT shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 32.7%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 32.7% Sentiment48/100

Weighted news tone is neutral across 56 relevant articles.

Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026 Insiders7 / 6

7 acquisitions and 6 disposals in the latest 180-day insider tape.

 Earnings5d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.09 USD0.5%1.74 USD5.44 USD1.17-14.112.4MOff
24 Jul 20262.08 USD-7.6%1.74 USD5.51 USD1.21-15.582.5MOff
17 Jul 20262.25 USD-1.7%1.75 USD5.59 USD1.27-11.953.1MOff
10 Jul 20262.29 USD10.1%1.76 USD5.65 USD1.23-15.564.9MOff
3 Jul 20262.08 USD9.5%1.76 USD5.72 USD1.23-23.455.8MOff
26 Jun 20261.90 USD9.2%1.78 USD5.78 USD1.30-31.0014.4MOff
19 Jun 20261.74 USD-5.9%1.82 USD5.85 USD1.09-40.915.8MOff
12 Jun 20261.85 USD-4.1%1.84 USD5.91 USD0.89-36.8710.8MOff
5 Jun 20261.93 USD39.9%1.85 USD5.98 USD0.60-34.0733.8MOff
29 May 20261.38 USD7.0%1.88 USD6.04 USD0.32-56.012.6MOff
22 May 20261.29 USD8.4%1.94 USD6.10 USD0.17-58.712.3MOff
15 May 20261.19 USD-21.7%2.01 USD6.17 USD-0.05-62.353.6MOff
8 May 20261.52 USD4.8%2.07 USD6.23 USD-0.31-53.303.1MOff
1 May 20261.45 USD5.1%2.11 USD6.28 USD-0.84-54.223.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.